EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Implementing calculated globulin screening for immunodeficiencies: The benefits and challenges

Stephen Jolles iD, Cecilia Poli iD, Nicholas L Rider iD, Gabriela Negritu iD, Til Rendschmidt iD, Antonio Condino-Neto iD

Journal of Human Immunity · 07.09.2026 · 2 (5)

DOI: 10.70962/jhi.20260028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Human Immunity, online erschienen am 16.07.2026. Verfasst von Stephen Jolles und 5 weiteren Autor:innen. Beteiligte Einrichtung: Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a need for pragmatic and cost-effective methodologies to facilitate earlier diagnosis of patients with primary and secondary immunodeficiencies, who often experience diagnostic delays that impact their quality of life, morbidity, and mortality. This review article will consider the utility of calculated globulin (CG) as a simple and unbiased screening tool for immunodeficiencies. We review literature indicating that CG can serve as an inexpensive and routinely performed proxy for immunoglobulin levels due to their established correlation. We also set out a workflow for the implementation of CG into clinical practice and discuss optimal approaches to embedding into laboratory reporting systems, and integration of AI approaches could expedite diagnoses. Finally, we discuss the challenges and pitfalls of CG screening, including the need for established CG cutoffs/action values across different patient age cohorts. Collaboration among biochemistry and immunology laboratories, clinicians, and patient organizations will be required to manage the logistics of effective broader implementation of CG screening into clinical practice.

Autor:innen und Institutionen

  • Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
  • Program of Immunogenetics and Translational Immunology, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
  • Department of Health Systems & Implementation Science Virginia Tech Carilion School of Medicine, Department of Pediatrics, Section of Allergy-Immunology, The Carilion Clinic, Roanoke, VA, USA.
  • CSL AG, Bern, Switzerland.
  • CSL GmbH, Marburg, Germany.
  • Jeffrey Modell Diagnostic and Research Center, São Paulo, Brazil.

ORCID-Profile: Stephen Jolles, Cecilia Poli, Nicholas L Rider, Gabriela Negritu, Til Rendschmidt, Antonio Condino-Neto

Förderung

  • CSL

Zitieren

APA

Jolles, S., Poli, C., Rider, N. L., Negritu, G., Rendschmidt, T., & Condino-Neto, A. (2026). Implementing calculated globulin screening for immunodeficiencies: The benefits and challenges. Journal of Human Immunity, 2(5). https://doi.org/10.70962/jhi.20260028

Vancouver

Jolles S, Poli C, Rider NL, Negritu G, Rendschmidt T, Condino-Neto A. Implementing calculated globulin screening for immunodeficiencies: The benefits and challenges. Journal of Human Immunity. 2026;2(5). doi:10.70962/jhi.20260028

BibTeX
@article{Jolles2026,
  author = {Jolles, Stephen and Poli, Cecilia and Rider, Nicholas L and Negritu, Gabriela and Rendschmidt, Til and Condino-Neto, Antonio},
  title = {Implementing calculated globulin screening for immunodeficiencies: The benefits and challenges},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {5},
  doi = {10.70962/jhi.20260028}
}
Kostenlos starten →